Streetbeat News

Products Services

EFTR

eFFECTOR Therapeutics Inc (NASDAQ:EFTR) released interim data from a Phase 1/2 study of zotatifin in ER+ metastatic breast cancer patients. The ZFA triplet cohort showed a median progression-free survival of 7.4 months with a 26% partial response rate. Zotatifin was well tolerated with most adverse events being Grade 1 or 2. No serious adverse events were observed in the new ZF dose escalation cohorts, and enrollment continues at higher doses. Additional data is expected in the first half of 2024. EFTR shares rose 2.94% to $0.59.

Portfolio Pulse from Vandana Singh

December 08, 2023 | 4:43 pm

CRSP

VRTX

The U.S. FDA has approved Casgevy, the first CRISPR gene-editing treatment for sickle cell disease, co-developed by Vertex Pharmaceuticals and CRISPR Therapeutics. The treatment, which could cost around $2 million per patient, is expected to generate $1.2 billion in sales by 2028. Casgevy has been approved for patients 12 years and older and uses CRISPR to edit DNA to turn on fetal hemoglobin. The complex treatment process includes chemotherapy and a hospital recovery period, and will be limited to certain health facilities.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 4:29 pm

BTCUSD

USDTUSD

El Salvador has launched the 'Adopting El Salvador Freedom Visa Program' to attract investors by offering citizenship to those who invest $1 million in Bitcoin (BTC) or Tether (USDT). The program is capped at 1,000 participants per year and aims to inject $1 billion into the Salvadoran economy. The investment will fund social development projects and position El Salvador as a tech and financial innovation hub.

Portfolio Pulse from Murtuza Merchant

December 08, 2023 | 4:23 pm

BMEA

Biomea Fusion's stock price has declined following the announcement of long-term follow-up data from its Phase II study of BMF-219 in adults with type 2 diabetes, which was presented at WCIRDC.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 3:49 pm

MSTR

MicroStrategy (NASDAQ:MSTR) has applied to the SEC to launch a yield-bearing ETF called 'MSTY' using a 'synthetic covered call' strategy, set for release in 2024. The ETF will trade MSTR derivatives, allowing investors to earn yields without owning MSTR shares directly. YieldMax, the ETF firm, has similar products for other tech companies. Analyst Eric Balchunas predicts the ETF could set a record for highest yield. MSTR's stock has seen significant gains, with a 294% increase year-to-date, buoyed by its substantial Bitcoin holdings.

Portfolio Pulse from Khyathi Dalal

December 08, 2023 | 3:29 pm

INTS

Intensity Therapeutics Inc (NASDAQ:INTS) reported positive Phase 2 trial results for INT230-6 in early-stage breast cancer patients, showing high tumor necrosis, immune activation, and a favorable safety profile. The data was presented at the 2023 San Antonio Breast Cancer Symposium, leading to a 150% surge in INTS stock price to $10.00.

Portfolio Pulse from Vandana Singh

December 08, 2023 | 3:22 pm

ADDDF

ASO

COLM

DKS

NKE

UA

Adidas (OTC:ADDDF) is recovering from a tough 2023, with better-than-expected Q3 results and a 50% stock increase this year, despite a 74% drop from its July 2022 peak. Nike (NYSE:NKE) shares are down 36% from their November 2021 high. The 2024 Paris Olympics and Euro 2024 are expected to boost visibility and sales for sportswear brands, with new sports like breaking (dance) aligning with brands like Nike, Adidas, Under Armour Inc (NYSE:UA), and retailers such as Dick's Sporting Goods Inc (NYSE:DKS), Columbia Sportswear Company (NASDAQ:COLM), and Academy Sports and Outdoors Inc (NASDAQ:ASO). Nike sponsors U.S., Japanese, and South Korean breaking federations, and Adidas signed the world's top female breaker. The sports apparel market is valued at $200 billion annually, and the 2024 events could significantly increase sales for these companies.

Portfolio Pulse from Neil Dennis

December 08, 2023 | 3:21 pm

NOC

Northrop Grumman successfully conducted a static test of its new SMART Demo solid rocket motor innovations at the Promontory, Utah test area.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 3:09 pm

RBLX

Roblox Corp (NYSE:RBLX) stock is experiencing an uptick due to reports of Nicki Minaj joining the platform for her new album release. A placeholder on Roblox hints at a potential game or event for 'Pink Friday 2'. Roblox's Q3 FY23 financials showed strong growth, with Bookings up 20% Y/Y and revenue up 38% Y/Y. DAUs and monthly unique payers also saw significant increases. The stock has risen over 46% YTD.

Portfolio Pulse from Anusuya Lahiri

December 08, 2023 | 2:58 pm

BTCUSD

Custodia Bank CEO Caitlin Long anticipates a bull market in 2024, especially with the upcoming Bitcoin halving. She highlights the launch of Custodia's Bitcoin custody service for institutions and warns of fraud in the crypto sector, referencing the legal issues faced by FTX's Sam Bankman-Fried and Binance's Changpeng Zhao. Long advocates for better U.S. crypto regulations and has contributed to Wyoming's pro-blockchain legislation, positioning the state as a blockchain hub.

Portfolio Pulse from Anthony Noto

December 08, 2023 | 2:56 pm